| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 42.271 | 46.861 | 58.899 | 63.426 | 72.165 | 75.276 | 96.026 | 104.473 |
| Total Income - EUR | - | - | 42.271 | 46.861 | 58.899 | 63.426 | 72.165 | 75.276 | 96.026 | 104.474 |
| Total Expenses - EUR | - | - | 23.816 | 20.702 | 22.927 | 29.811 | 23.100 | 33.913 | 31.951 | 37.544 |
| Gross Profit/Loss - EUR | - | - | 18.455 | 26.160 | 35.972 | 33.616 | 49.064 | 41.363 | 64.075 | 66.930 |
| Net Profit/Loss - EUR | - | - | 18.033 | 25.691 | 35.383 | 32.981 | 48.333 | 40.599 | 63.115 | 58.676 |
| Employees | - | - | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 2 |
Check the financial reports for the company - Dr. Micu Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 114 | 112 | 260 | 255 | 105 | 1.488 | 794 | 1.504 |
| Current Assets | - | - | 20.257 | 39.552 | 69.992 | 57.056 | 90.449 | 54.450 | 64.233 | 107.253 |
| Inventories | - | - | 3.448 | 0 | 0 | 0 | 0 | 183 | 0 | 40.497 |
| Receivables | - | - | 12.046 | 3.308 | 46.121 | 37.365 | 48.025 | 51.053 | 57.717 | 1.091 |
| Cash | - | - | 4.763 | 36.244 | 23.871 | 19.692 | 42.423 | 3.215 | 6.516 | 65.665 |
| Shareholders Funds | - | - | 18.076 | 38.399 | 68.823 | 55.331 | 88.521 | 44.014 | 63.047 | 99.560 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 80 |
| Debts | - | - | 2.294 | 1.265 | 1.429 | 1.981 | 2.033 | 11.923 | 1.980 | 9.197 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr. Micu Srl